Advancing genetic testing for deafness with genomic technology

Area of Science:

• Genetics
• Audiology
• Molecular Biology

Background:

• Non-syndromic hearing loss (NSHL) is a common human sensory impairment with significant genetic heterogeneity.
• Previous genetic testing for NSHL was limited due to its complexity.
• Advancements in sequencing technology enable more comprehensive genetic analysis.

Purpose of the Study:

• To establish optimized targeted genomic enrichment (TGE) and massively parallel sequencing (MPS) protocols for NSHL genetic diagnosis.
• To determine sequencing requirements for maximum variant sensitivity and define quality metrics for variant validation.
• To assess the diagnostic yield of TGE-MPS in a cohort of 100 individuals with presumed genetic NSHL.

Main Methods:

• DNA from 100 probands with presumed genetic NSHL was analyzed.
• Targeted genomic enrichment (TGE) with post-capture multiplexing was performed, followed by Illumina sequencing.
• Bioinformatics analysis was conducted using a local Galaxy installation on a high-performance computing cluster.

Main Results:

• Approximately 3.2-6.3 million mapped sequencing reads per sample were required for maximum variant sensitivity.
• Sanger validation was unnecessary for 95% of variants based on quality score analysis.
• An overall diagnostic rate of 42% was achieved, with variations based on clinical presentation (e.g., 56% for bilateral autosomal recessive NSHL).

Conclusions:

• The study provides a framework for utilizing TGE and MPS strategies in NSHL genetic diagnosis.
• The diagnostic rate underscores the need for further research into novel gene discovery and non-exonic mutations in genetic deafness.
• Unsolved cases represent a valuable resource for future research in genetic hearing loss.